FDA Approves Botox for Migraine Prevention
The US Food and Drug Administration has recently approved Botox (onabotulinumtoxinA) injection as a safe and effective method to combat and prevent chronic migraines amongst the individuals who suffer from the painful headaches for more than two weeks in a month.
This is clearly a welcome note for the considerable three million plus Americans who experience migraines.
In the past, Botox in its purified form has been approved as a way to fight off wrinkles. Now, according to the FDA, doctors can give the medication in multiple injections in specific muscles near the head and the neck once every three months to achieve maximum relief for the concerned client. The adverse reactions, according to the department are headache and neck pain. The said treatment regimen has fortunately been given the approval for coverage of insurance companies.
However, as of the moment, the Botox injection does not apply to migraines happening in two weeks or less in a month.
Nov 10, 2010